Circulating extracellular DNA is in association with continuous metabolic syndrome score in healthy adolescents
Obesity is associated with chronic low-grade inflammation that eventually leads to metabolic complications. Extracellular DNA (ecDNA) is a damage-associated molecular pattern. Extracellular mitochondrial DNA can activate innate immunity. We hypothesized that ecDNA, especially of mitochondrial origin...
Saved in:
| Published in | Physiological genomics Vol. 53; no. 7; pp. 309 - 318 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
American Physiological Society
01.07.2021
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1094-8341 1531-2267 1531-2267 |
| DOI | 10.1152/physiolgenomics.00029.2021 |
Cover
| Abstract | Obesity is associated with chronic low-grade inflammation that eventually leads to metabolic complications. Extracellular DNA (ecDNA) is a damage-associated molecular pattern. Extracellular mitochondrial DNA can activate innate immunity. We hypothesized that ecDNA, especially of mitochondrial origin, could be associated with components of the metabolic syndrome in young healthy probands. In a cross-sectional study, healthy adolescents ( n = 1,249) provided blood samples. Anthropometric data, blood pressure, and blood counts were assessed. In addition, biochemical analysis of sera or plasma was conducted, including the quantification of advanced oxidation protein products (AOPPs) as a marker of oxidative stress induced by neutrophil or monocyte activation. Plasma ecDNA was isolated and measured by fluorometry. Nuclear and mitochondrial DNA were quantified by real-time PCR. Males had higher total plasma ecDNA [15 (11–21) vs. 11 (8–17) ng/mL; median (interquartile range)], nuclear [1,760 (956–3,273) vs. 1,153 (600–2,292) genome equivalents (GE)/mL], and mitochondrial [37,181 (14,836–90,896) vs. 30,089 (12,587–72,286) GE/mL] DNA. ecDNA correlated positively with the continuous metabolic syndrome score ( r = 0.158 for males and r = 0.134 for females). Stronger correlations were found between ecDNA of mitochondrial origin and AOPP ( r = 0.202 and 0.186 for males and females, respectively). Multivariate regression analysis revealed associations of nuclear DNA with leukocyte and erythrocyte counts. The results of this study of healthy adolescents show that circulating ecDNA is associated with the risk of metabolic syndrome, not with obesity per se. The association between mitochondrial ecDNA and AOPP requires further attention as it supports a potential role of mitochondria-induced sterile inflammation in the pathogenesis of the metabolic syndrome. |
|---|---|
| AbstractList | Obesity is associated with chronic low-grade inflammation that eventually leads to metabolic complications. Extracellular DNA (ecDNA) is a damage-associated molecular pattern. Extracellular mitochondrial DNA can activate innate immunity. We hypothesized that ecDNA, especially of mitochondrial origin, could be associated with components of the metabolic syndrome in young healthy probands. In a cross-sectional study, healthy adolescents ( n = 1,249) provided blood samples. Anthropometric data, blood pressure, and blood counts were assessed. In addition, biochemical analysis of sera or plasma was conducted, including the quantification of advanced oxidation protein products (AOPPs) as a marker of oxidative stress induced by neutrophil or monocyte activation. Plasma ecDNA was isolated and measured by fluorometry. Nuclear and mitochondrial DNA were quantified by real-time PCR. Males had higher total plasma ecDNA [15 (11–21) vs. 11 (8–17) ng/mL; median (interquartile range)], nuclear [1,760 (956–3,273) vs. 1,153 (600–2,292) genome equivalents (GE)/mL], and mitochondrial [37,181 (14,836–90,896) vs. 30,089 (12,587–72,286) GE/mL] DNA. ecDNA correlated positively with the continuous metabolic syndrome score ( r = 0.158 for males and r = 0.134 for females). Stronger correlations were found between ecDNA of mitochondrial origin and AOPP ( r = 0.202 and 0.186 for males and females, respectively). Multivariate regression analysis revealed associations of nuclear DNA with leukocyte and erythrocyte counts. The results of this study of healthy adolescents show that circulating ecDNA is associated with the risk of metabolic syndrome, not with obesity per se. The association between mitochondrial ecDNA and AOPP requires further attention as it supports a potential role of mitochondria-induced sterile inflammation in the pathogenesis of the metabolic syndrome. Obesity is associated with chronic low-grade inflammation that eventually leads to metabolic complications. Extracellular DNA (ecDNA) is a damage-associated molecular pattern. Extracellular mitochondrial DNA can activate innate immunity. We hypothesized that ecDNA, especially of mitochondrial origin, could be associated with components of the metabolic syndrome in young healthy probands. In a cross-sectional study, healthy adolescents ( = 1,249) provided blood samples. Anthropometric data, blood pressure, and blood counts were assessed. In addition, biochemical analysis of sera or plasma was conducted, including the quantification of advanced oxidation protein products (AOPPs) as a marker of oxidative stress induced by neutrophil or monocyte activation. Plasma ecDNA was isolated and measured by fluorometry. Nuclear and mitochondrial DNA were quantified by real-time PCR. Males had higher total plasma ecDNA [15 (11-21) vs. 11 (8-17) ng/mL; median (interquartile range)], nuclear [1,760 (956-3,273) vs. 1,153 (600-2,292) genome equivalents (GE)/mL], and mitochondrial [37,181 (14,836-90,896) vs. 30,089 (12,587-72,286) GE/mL] DNA. ecDNA correlated positively with the continuous metabolic syndrome score ( = 0.158 for males and = 0.134 for females). Stronger correlations were found between ecDNA of mitochondrial origin and AOPP ( = 0.202 and 0.186 for males and females, respectively). Multivariate regression analysis revealed associations of nuclear DNA with leukocyte and erythrocyte counts. The results of this study of healthy adolescents show that circulating ecDNA is associated with the risk of metabolic syndrome, not with obesity per se. The association between mitochondrial ecDNA and AOPP requires further attention as it supports a potential role of mitochondria-induced sterile inflammation in the pathogenesis of the metabolic syndrome. Obesity is associated with chronic low-grade inflammation that eventually leads to metabolic complications. Extracellular DNA (ecDNA) is a damage-associated molecular pattern. Extracellular mitochondrial DNA can activate innate immunity. We hypothesized that ecDNA, especially of mitochondrial origin, could be associated with components of the metabolic syndrome in young healthy probands. In a cross-sectional study, healthy adolescents (n = 1,249) provided blood samples. Anthropometric data, blood pressure, and blood counts were assessed. In addition, biochemical analysis of sera or plasma was conducted, including the quantification of advanced oxidation protein products (AOPPs) as a marker of oxidative stress induced by neutrophil or monocyte activation. Plasma ecDNA was isolated and measured by fluorometry. Nuclear and mitochondrial DNA were quantified by real-time PCR. Males had higher total plasma ecDNA [15 (11-21) vs. 11 (8-17) ng/mL; median (interquartile range)], nuclear [1,760 (956-3,273) vs. 1,153 (600-2,292) genome equivalents (GE)/mL], and mitochondrial [37,181 (14,836-90,896) vs. 30,089 (12,587-72,286) GE/mL] DNA. ecDNA correlated positively with the continuous metabolic syndrome score (r = 0.158 for males and r = 0.134 for females). Stronger correlations were found between ecDNA of mitochondrial origin and AOPP (r = 0.202 and 0.186 for males and females, respectively). Multivariate regression analysis revealed associations of nuclear DNA with leukocyte and erythrocyte counts. The results of this study of healthy adolescents show that circulating ecDNA is associated with the risk of metabolic syndrome, not with obesity per se. The association between mitochondrial ecDNA and AOPP requires further attention as it supports a potential role of mitochondria-induced sterile inflammation in the pathogenesis of the metabolic syndrome.Obesity is associated with chronic low-grade inflammation that eventually leads to metabolic complications. Extracellular DNA (ecDNA) is a damage-associated molecular pattern. Extracellular mitochondrial DNA can activate innate immunity. We hypothesized that ecDNA, especially of mitochondrial origin, could be associated with components of the metabolic syndrome in young healthy probands. In a cross-sectional study, healthy adolescents (n = 1,249) provided blood samples. Anthropometric data, blood pressure, and blood counts were assessed. In addition, biochemical analysis of sera or plasma was conducted, including the quantification of advanced oxidation protein products (AOPPs) as a marker of oxidative stress induced by neutrophil or monocyte activation. Plasma ecDNA was isolated and measured by fluorometry. Nuclear and mitochondrial DNA were quantified by real-time PCR. Males had higher total plasma ecDNA [15 (11-21) vs. 11 (8-17) ng/mL; median (interquartile range)], nuclear [1,760 (956-3,273) vs. 1,153 (600-2,292) genome equivalents (GE)/mL], and mitochondrial [37,181 (14,836-90,896) vs. 30,089 (12,587-72,286) GE/mL] DNA. ecDNA correlated positively with the continuous metabolic syndrome score (r = 0.158 for males and r = 0.134 for females). Stronger correlations were found between ecDNA of mitochondrial origin and AOPP (r = 0.202 and 0.186 for males and females, respectively). Multivariate regression analysis revealed associations of nuclear DNA with leukocyte and erythrocyte counts. The results of this study of healthy adolescents show that circulating ecDNA is associated with the risk of metabolic syndrome, not with obesity per se. The association between mitochondrial ecDNA and AOPP requires further attention as it supports a potential role of mitochondria-induced sterile inflammation in the pathogenesis of the metabolic syndrome. |
| Author | Šebeková, Katarína Janovičová, Ĺubica Gardlík, Roman Koborová, Ivana Celec, Peter Gurecká, Radana |
| Author_xml | – sequence: 1 givenname: Peter orcidid: 0000-0001-5883-3580 surname: Celec fullname: Celec, Peter organization: Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia, Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia, Department of Molecular Biology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia – sequence: 2 givenname: Ĺubica surname: Janovičová fullname: Janovičová, Ĺubica organization: Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia – sequence: 3 givenname: Radana surname: Gurecká fullname: Gurecká, Radana organization: Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia, Institute of Medical Physics, Biophysics, Informatics and Telemedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia – sequence: 4 givenname: Ivana surname: Koborová fullname: Koborová, Ivana organization: Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia – sequence: 5 givenname: Roman surname: Gardlík fullname: Gardlík, Roman organization: Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia, Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia – sequence: 6 givenname: Katarína orcidid: 0000-0002-9641-9265 surname: Šebeková fullname: Šebeková, Katarína organization: Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34097532$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkUtvFDEQhC0URJKFv4AsuHCZxY_xPDgRLY8gReQSzqMe25N15LEXt0dh_z3eJHDYUy62ZX3Vqq46JychBkvIO87WnCvxcbfdo4v-1oY4O41rxpjo14IJ_oKccSV5JUTTnpQ36-uqkzU_JeeId4zxuu3UK3Iqa9a3SoozEjcu6cVDduGW2j85gbbel49Ev_y8oA6pCxQQo3aFiYHeu7ylOoYiWOKCdLYZxuidprgPJsXZUtQx2YNua8Hn7Z6Cid6itiHja_JyAo_2zdO9Ir--fb3ZXFZX199_bC6uKi3rNlcc6lZC24Eei_2-NiOrG6N7NXLTKNMIDdpwU_aEqWnASmMAJO-nvpuMajq5Ih8e5-5S_L1YzMPs8LAaBFtsD0LJXrC2HAV9f4TexSWF4q5QquOqUyXUFXn7RC3jbM2wS26GtB_-RVmAT4-AThEx2ek_wtlw6G046m146G049FbEn4_E2uWHwEsjzj9nxF8lU6j4 |
| CitedBy_id | crossref_primary_10_1007_s11357_022_00590_8 crossref_primary_10_3390_nu17020241 crossref_primary_10_1111_obr_13674 crossref_primary_10_1038_s41598_025_86857_4 crossref_primary_10_3390_biomedicines13020502 crossref_primary_10_3390_biomedicines11092514 crossref_primary_10_1038_s41598_023_28903_7 crossref_primary_10_4240_wjgs_v14_i9_887 |
| Cites_doi | 10.1016/j.jtcvs.2018.09.043 10.1084/jem.20120201 10.7754/clin.lab.2015.141239 10.1016/j.diabet.2018.06.004 10.1016/j.atherosclerosis.2013.12.022 10.1385/ENDO:13:2:155 10.1016/j.clim.2012.04.006 10.1038/nm.3887 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 10.2337/dc06-134 10.1111/j.1399-5448.2007.00271.x 10.1038/s41598-019-41593-4 10.1007/s10522-019-09808-3 10.1073/pnas.1500076112 10.1016/j.biopha.2017.06.009 10.1007/s10096-016-2805-7 10.1182/bloodadvances.2018018895 10.1038/nrg2468 10.1038/s41598-020-70526-9 10.1111/acel.12890 10.4049/jimmunol.161.5.2524 10.1373/clinchem.2017.272401 10.1007/s10555-016-9629-x 10.1097/SHK.0000000000001215 10.1373/clinchem.2007.101030 10.1186/s12916-014-0207-1 10.1038/oby.2012.138 10.1093/ndt/gfv454 10.1093/clinchem/48.3.421 10.1017/erm.2017.12 10.4049/jimmunol.1201719 10.1371/journal.pone.0069805 10.1186/s13054-018-2109-7 10.1186/1755-8794-7-54 10.1016/j.ajhg.2020.01.008 10.1186/s40246-019-0244-0 10.1097/MED.0b013e3282f43d19 10.1152/ajpgi.00446.2016 10.1073/pnas.1815031116 10.3390/ijms21218062 10.3389/fmed.2020.593316 10.1016/j.numecd.2015.11.008 10.1161/01.CIR.0000111245.75752.C6 10.15252/embr.201949799 10.1038/s41467-018-07466-6 10.1126/science.abe7199 10.1007/s00592-019-01471-x 10.1373/clinchem.2013.203679 10.1111/j.1467-789X.2009.00674.x 10.1002/pd.3919 10.1007/s00414-019-02240-9 10.1126/sciadv.1501332 10.1038/s41598-020-72393-w 10.1371/journal.pone.0039853 10.1136/bmjdrc-2020-001372 10.1371/journal.pone.0223470 10.1373/clinchem.2018.298323 10.1186/s41232-020-00118-7 10.1016/j.bcp.2010.01.013 10.21101/cejph.a4968 10.1126/science.1092385 10.1016/j.annepidem.2010.08.001 10.1159/000510088 10.1038/nature08780 10.7754/clin.lab.2014.141132 10.1146/annurev-immunol-031210-101322 10.3390/cells8040328 10.1161/CIRCULATIONAHA.105.169404 10.1371/journal.pone.0146143 10.1038/ki.1996.186 10.1097/SHK.0b013e3181cd8c08 10.1016/j.diabres.2008.04.002 10.3390/ijms20174163 10.1371/journal.pone.0129311 10.1038/s41598-020-74288-2 10.33549/physiolres.934242 10.3389/fphys.2019.01607 10.1186/1475-2840-7-17 |
| ContentType | Journal Article |
| Copyright | Copyright American Physiological Society Jul 2021 |
| Copyright_xml | – notice: Copyright American Physiological Society Jul 2021 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TM 8FD FR3 P64 RC3 7X8 |
| DOI | 10.1152/physiolgenomics.00029.2021 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Nucleic Acids Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Engineering Research Database Technology Research Database Nucleic Acids Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic Genetics Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry Biology |
| EISSN | 1531-2267 |
| EndPage | 318 |
| ExternalDocumentID | 34097532 10_1152_physiolgenomics_00029_2021 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Slovakia |
| GeographicLocations_xml | – name: Slovakia |
| GroupedDBID | --- 123 29O 2WC 4.4 5VS AAFWJ AAYXX ABHWK ABJNI ABKWE ACGFS ACPRK ADBBV ADFNX AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CITATION CS3 DIK DU5 E3Z EBS EMOBN F5P H13 ITBOX KQ8 OK1 P2P R.V RAP RHI RPRKH TR2 W8F WOQ XSW CGR CUY CVF ECM EIF NPM 7TM 8FD FR3 P64 RC3 7X8 |
| ID | FETCH-LOGICAL-c347t-1a473a78acb34194db046dc95b1d65d62cacd1d226af66ae3ddaa319f98fd5683 |
| ISSN | 1094-8341 1531-2267 |
| IngestDate | Fri Jul 11 15:22:44 EDT 2025 Mon Jun 30 02:45:47 EDT 2025 Thu Apr 03 07:01:34 EDT 2025 Tue Jul 01 01:03:53 EDT 2025 Thu Apr 24 23:00:14 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | metabolic syndrome cell-free DNA microinflammation obesity observational study |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c347t-1a473a78acb34194db046dc95b1d65d62cacd1d226af66ae3ddaa319f98fd5683 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-5883-3580 0000-0002-9641-9265 |
| PMID | 34097532 |
| PQID | 2558158515 |
| PQPubID | 2047828 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_2539207392 proquest_journals_2558158515 pubmed_primary_34097532 crossref_primary_10_1152_physiolgenomics_00029_2021 crossref_citationtrail_10_1152_physiolgenomics_00029_2021 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-07-01 20210701 |
| PublicationDateYYYYMMDD | 2021-07-01 |
| PublicationDate_xml | – month: 07 year: 2021 text: 2021-07-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Bethesda |
| PublicationTitle | Physiological genomics |
| PublicationTitleAlternate | Physiol Genomics |
| PublicationYear | 2021 |
| Publisher | American Physiological Society |
| Publisher_xml | – name: American Physiological Society |
| References | B20 B64 B21 B65 B22 B66 B23 B67 B24 B68 B25 B69 B26 B27 B28 B29 B71 B73 B30 B74 B31 B75 B32 B76 B33 B77 B34 B78 B35 B79 B36 B37 B38 B39 Witko-Sarsat V (B70) 1998; 161 B1 B2 B3 B4 B5 B6 B7 B8 B9 B40 B41 B42 B43 B44 B45 B46 B47 B48 B49 B50 B51 B52 B53 B10 B54 B11 B55 B12 B56 B13 B57 B14 B58 B15 B59 B16 B17 B18 B19 B60 B61 B62 B63 |
| References_xml | – ident: B34 doi: 10.1016/j.jtcvs.2018.09.043 – ident: B76 doi: 10.1084/jem.20120201 – ident: B67 doi: 10.7754/clin.lab.2015.141239 – ident: B39 doi: 10.1016/j.diabet.2018.06.004 – ident: B57 doi: 10.1016/j.atherosclerosis.2013.12.022 – ident: B1 doi: 10.1385/ENDO:13:2:155 – ident: B11 doi: 10.1016/j.clim.2012.04.006 – ident: B24 doi: 10.1038/nm.3887 – ident: B25 doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S – ident: B28 doi: 10.2337/dc06-134 – ident: B27 doi: 10.1111/j.1399-5448.2007.00271.x – ident: B58 doi: 10.1038/s41598-019-41593-4 – ident: B75 doi: 10.1007/s10522-019-09808-3 – ident: B63 doi: 10.1073/pnas.1500076112 – ident: B12 doi: 10.1016/j.biopha.2017.06.009 – ident: B65 doi: 10.1007/s10096-016-2805-7 – ident: B51 doi: 10.1182/bloodadvances.2018018895 – ident: B4 doi: 10.1038/nrg2468 – ident: B49 doi: 10.1038/s41598-020-70526-9 – ident: B68 doi: 10.1111/acel.12890 – volume: 161 start-page: 2524 year: 1998 ident: B70 publication-title: J Immunol doi: 10.4049/jimmunol.161.5.2524 – ident: B74 doi: 10.1373/clinchem.2017.272401 – ident: B45 doi: 10.1007/s10555-016-9629-x – ident: B52 doi: 10.1097/SHK.0000000000001215 – ident: B33 doi: 10.1373/clinchem.2007.101030 – ident: B32 doi: 10.1186/s12916-014-0207-1 – ident: B17 doi: 10.1038/oby.2012.138 – ident: B37 doi: 10.1093/ndt/gfv454 – ident: B10 doi: 10.1093/clinchem/48.3.421 – ident: B35 doi: 10.1017/erm.2017.12 – ident: B22 doi: 10.4049/jimmunol.1201719 – ident: B64 doi: 10.1371/journal.pone.0069805 – ident: B71 doi: 10.1186/s13054-018-2109-7 – ident: B48 doi: 10.1186/1755-8794-7-54 – ident: B61 doi: 10.1016/j.ajhg.2020.01.008 – ident: B15 doi: 10.1186/s40246-019-0244-0 – ident: B2 doi: 10.1097/MED.0b013e3282f43d19 – ident: B13 doi: 10.1152/ajpgi.00446.2016 – ident: B62 doi: 10.1073/pnas.1815031116 – ident: B9 doi: 10.3390/ijms21218062 – ident: B14 doi: 10.3389/fmed.2020.593316 – ident: B23 doi: 10.1016/j.numecd.2015.11.008 – ident: B3 doi: 10.1161/01.CIR.0000111245.75752.C6 – ident: B53 doi: 10.15252/embr.201949799 – ident: B73 doi: 10.1038/s41467-018-07466-6 – ident: B59 doi: 10.1126/science.abe7199 – ident: B40 doi: 10.1007/s00592-019-01471-x – ident: B66 doi: 10.1373/clinchem.2013.203679 – ident: B5 doi: 10.1111/j.1467-789X.2009.00674.x – ident: B16 doi: 10.1002/pd.3919 – ident: B69 doi: 10.1007/s00414-019-02240-9 – ident: B18 doi: 10.1126/sciadv.1501332 – ident: B20 doi: 10.1038/s41598-020-72393-w – ident: B44 doi: 10.1371/journal.pone.0039853 – ident: B56 doi: 10.1136/bmjdrc-2020-001372 – ident: B79 doi: 10.1371/journal.pone.0223470 – ident: B78 doi: 10.1373/clinchem.2018.298323 – ident: B8 doi: 10.1186/s41232-020-00118-7 – ident: B77 doi: 10.1016/j.bcp.2010.01.013 – ident: B47 doi: 10.21101/cejph.a4968 – ident: B21 doi: 10.1126/science.1092385 – ident: B30 doi: 10.1016/j.annepidem.2010.08.001 – ident: B42 doi: 10.1159/000510088 – ident: B54 doi: 10.1038/nature08780 – ident: B43 doi: 10.7754/clin.lab.2014.141132 – ident: B7 doi: 10.1146/annurev-immunol-031210-101322 – ident: B41 doi: 10.3390/cells8040328 – ident: B26 doi: 10.1161/CIRCULATIONAHA.105.169404 – ident: B31 doi: 10.1371/journal.pone.0146143 – ident: B38 doi: 10.1038/ki.1996.186 – ident: B19 doi: 10.1097/SHK.0b013e3181cd8c08 – ident: B46 doi: 10.1016/j.diabres.2008.04.002 – ident: B60 doi: 10.3390/ijms20174163 – ident: B36 doi: 10.1371/journal.pone.0129311 – ident: B50 doi: 10.1038/s41598-020-74288-2 – ident: B55 doi: 10.33549/physiolres.934242 – ident: B6 doi: 10.3389/fphys.2019.01607 – ident: B29 doi: 10.1186/1475-2840-7-17 |
| SSID | ssj0014785 |
| Score | 2.381259 |
| Snippet | Obesity is associated with chronic low-grade inflammation that eventually leads to metabolic complications. Extracellular DNA (ecDNA) is a damage-associated... |
| SourceID | proquest pubmed crossref |
| SourceType | Aggregation Database Index Database Enrichment Source |
| StartPage | 309 |
| SubjectTerms | Adolescent Adolescents Advanced Oxidation Protein Products - blood Biochemical analysis Biomarkers - blood Blood Pressure Cell activation Cell-Free Nucleic Acids - blood Child Cross-Sectional Studies DNA damage DNA, Mitochondrial - blood Female Fluorometry Genomes Humans Inflammation Innate immunity Leukocytes (neutrophilic) Male Males Metabolic syndrome Metabolic Syndrome - blood Metabolic Syndrome - epidemiology Metabolic Syndrome - genetics Mitochondrial DNA Monocytes Obesity Oxidative stress Prevalence Regression Analysis Risk Factors Slovakia - epidemiology Teenagers Young Adult |
| Title | Circulating extracellular DNA is in association with continuous metabolic syndrome score in healthy adolescents |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34097532 https://www.proquest.com/docview/2558158515 https://www.proquest.com/docview/2539207392 |
| Volume | 53 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1531-2267 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0014785 issn: 1094-8341 databaseCode: KQ8 dateStart: 19990701 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1531-2267 dateEnd: 20241028 omitProxy: true ssIdentifier: ssj0014785 issn: 1094-8341 databaseCode: DIK dateStart: 19990101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIqAXBOXRQEGLxK0y1N6H7WNJgD5ED6iVerPWu7ZkldhR4kRq_wp_lpm113FKIxUuVuT1-rHfl_HMevYbQj5qFYZRHnAvNizwuMx8L06V8A7STGjAXxk74fbjTB5d8JNLcTkY_O5lLS3q9JO-uXNdyf-gCvsAV1wl-w_IdieFHfAb8IUtIAzbe2E8Kmbalt-CcB-M7EzhNLzNKx2fHWKp8qLcV6vx7_LMocMCU18nWQ0cQJlrJ1ywP0dZS-zXLJC8vi355BxZmznaGU5Uep308uZHWF3nr_TfE1VWy8K6r-NqaT_R-3gQ7vkSL9Je2tD3BVjiq9UhP5VRZdd6WgFz-2c4XrrWdgIj8LtkV3j_OKPre-AGhn2r3EgIt-wLeyaWWTmFO0y_QCnZafP07rFRnjLA9UjNMuweJ6YTSwqGel-inWJdF952TQ_IwwBeGVgXZHx82n2i4mEkWhVbuPTnzRfeJo_dqdadnw0RjfVszp-Rp21IQg8bfj0ng6zcIY-aIqXXO-TJyNUEfEGqHuPoGuMoMI4Wc1qUtMc4ioyjK8bRjnHUMY5axmG_lnG0x7iX5OLb1_PRkdeW7PA042Ht-YqHTIWR0ikKBXKTHnBpdCxS30hhZKCVNr4BsFUupcqYMUrBWyCPo9wIGbFXZKusymyXUBmBZxv5Is90yhW4pTljQSSZzHjgp3kwJLEby0S3evZYVuVXYuNaESS3IEksJAlCMiSs6zttVF3u1WvPQZa0VmCeQEgONwlxixiSD10zwILjr8oMxhaOgSgEP4nDTb9uoO4u66jxZmPLW7K9-tvska16tsjegSdcp-8tI_8Af5O4iw |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Circulating+extracellular+DNA+is+in+association+with+continuous+metabolic+syndrome+score+in+healthy+adolescents&rft.jtitle=Physiological+genomics&rft.au=Celec%2C+Peter&rft.au=Janovi%C4%8Dov%C3%A1%2C+%C4%B9ubica&rft.au=Gureck%C3%A1%2C+Radana&rft.au=Koborov%C3%A1%2C+Ivana&rft.date=2021-07-01&rft.eissn=1531-2267&rft.volume=53&rft.issue=7&rft.spage=309&rft_id=info:doi/10.1152%2Fphysiolgenomics.00029.2021&rft_id=info%3Apmid%2F34097532&rft.externalDocID=34097532 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1094-8341&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1094-8341&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1094-8341&client=summon |